Menu
Back to Journals » OncoTargets and Therapy » Volume 8
Review
Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,769 | Dovepress* | 8,020+ | 1,823 | 9,843 | |
| PubMed Central* | 1,749 | 702 | 2,451 | ||
| Totals | 9,769 | 2,525 | 12,294 | ||
|
*Since 20 April 2015 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar